eFigure2 from Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Abstract
Tumor mutational burden in known PD-L1-positive and negative tumors (n = 37)